Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women

This open-labeled non-inferiority trial evaluated immunogenicity and reactogenicity of heterologous and homologous COVID-19 vaccination schedules in pregnant Thai women. 18–45-year-old pregnant women with no history of COVID-19 infection or vaccination and a gestational age of ≥12 weeks were randomi...

Full description

Bibliographic Details
Main Authors: Chenchit Chayachinda, Kanokwaroon Watananirun, Chayawat Phatihattakorn, Sanitra Anuwutnavin, Suvimol Niyomnaitham, Wanatpreeya Phongsamart, Keswadee Lapphra, Orasri Wittawatmongkol, Supattra Rungmaitree, Laddawan Jansarikit, Kobporn Boonnak, Patimaporn Wongprompitak, Sansnee Senawong, Avishek Upadhya, Zheng Quan Toh, Paul V. Licciardi, Kulkanya Chokephaibulkit
Format: Article
Language:English
Published: Taylor & Francis Group 2023-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
heterologous schedules
homologous schedules
bnt162b2
chadox1
coronavac
thailand
Online Access:http://dx.doi.org/10.1080/21645515.2023.2228670

Internet

http://dx.doi.org/10.1080/21645515.2023.2228670

Similar Items